309 related articles for article (PubMed ID: 25993630)
1. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
Rodan LH; Wells GD; Banks L; Thompson S; Schneiderman JE; Tein I
PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
[TBL] [Abstract][Full Text] [Related]
2. L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome.
Rodan LH; Poublanc J; Fisher JA; Sobczyk O; Mikulis DJ; Tein I
PLoS One; 2020; 15(9):e0238224. PubMed ID: 32881886
[TBL] [Abstract][Full Text] [Related]
3. High cytochrome c oxidase expression links to severe skeletal energy failure by (31)P-MRS spectroscopy in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.
Liu AH; Niu FN; Chang LL; Zhang B; Liu Z; Chen JY; Zhou Q; Wu HY; Xu Y
CNS Neurosci Ther; 2014 Jun; 20(6):509-14. PubMed ID: 24674659
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of MELAS and L-arginine effects.
Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
[TBL] [Abstract][Full Text] [Related]
5. MELAS: Monitoring treatment with magnetic resonance spectroscopy.
Hovsepian DA; Galati A; Chong RA; Mazumder R; DeGiorgio CM; Mishra S; Yim C
Acta Neurol Scand; 2019 Jan; 139(1):82-85. PubMed ID: 30216413
[TBL] [Abstract][Full Text] [Related]
6. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
El-Hattab AW; Adesina AM; Jones J; Scaglia F
Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy in patients with MELAS.
Möller HE; Kurlemann G; Pützler M; Wiedermann D; Hilbich T; Fiedler B
J Neurol Sci; 2005 Mar; 229-230():131-9. PubMed ID: 15760631
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F
Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347
[TBL] [Abstract][Full Text] [Related]
9. Reversal of Stroke-Like Episodes With L-Arginine and Meticulous Perioperative Management of Renal Transplantation in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome. Case Report.
Al Yazidi G; Mulder J; Licht C; Harvey E; Robertson J; Sondheimer N; Tein I
Neurohospitalist; 2022 Jan; 12(1):67-73. PubMed ID: 34950389
[TBL] [Abstract][Full Text] [Related]
10. MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin.
Penn AM; Lee JW; Thuillier P; Wagner M; Maclure KM; Menard MR; Hall LD; Kennaway NG
Neurology; 1992 Nov; 42(11):2147-52. PubMed ID: 1436526
[TBL] [Abstract][Full Text] [Related]
11. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
Yoneda M; Ikawa M; Arakawa K; Kudo T; Kimura H; Fujibayashi Y; Okazawa H
Biochim Biophys Acta; 2012 May; 1820(5):615-8. PubMed ID: 21600268
[TBL] [Abstract][Full Text] [Related]
12. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
Sudo A; Sano H; Kawamura N
No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430
[TBL] [Abstract][Full Text] [Related]
13. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.
El-Hattab AW; Emrick LT; Hsu JW; Chanprasert S; Almannai M; Craigen WJ; Jahoor F; Scaglia F
Mol Genet Metab; 2016 Apr; 117(4):407-12. PubMed ID: 26851065
[TBL] [Abstract][Full Text] [Related]
14. High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.
Guerrero-Molina MP; Morales-Conejo M; Delmiro A; Morán M; Domínguez-González C; Arranz-Canales E; Ramos-González A; Arenas J; Martín MA; de la Aleja JG
Eur J Neurol; 2023 Feb; 30(2):538-547. PubMed ID: 36334048
[TBL] [Abstract][Full Text] [Related]
15. ATP, phosphocreatine and lactate in exercising muscle in mitochondrial disease and McArdle's disease.
Löfberg M; Lindholm H; Näveri H; Majander A; Suomalainen A; Paetau A; Sovijärvi A; Härkönen M; Somer H
Neuromuscul Disord; 2001 May; 11(4):370-5. PubMed ID: 11369188
[TBL] [Abstract][Full Text] [Related]
16. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS).
Li X; Wang Y; Wang Z; Lu J; Xu Y; Ye J; Kuang Z; Li B; Pan M; Chen W; Lu S; Zhou Z; Cheng L; Wang H
J Clin Neurosci; 2018 Sep; 55():65-70. PubMed ID: 29921486
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
Niu FN; Meng HL; Chang LL; Wu HY; Li WP; Liu RY; Wang HT; Zhang B; Xu Y
CNS Neurosci Ther; 2017 Aug; 23(8):686-697. PubMed ID: 28695670
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of L-arginine for stroke-like episode in MELAS.
Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M
Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086
[TBL] [Abstract][Full Text] [Related]
19. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
[TBL] [Abstract][Full Text] [Related]
20. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.
Ganetzky RD; Falk MJ
Mol Genet Metab; 2018 Mar; 123(3):301-308. PubMed ID: 29428506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
